QSAR, Docking and ADMET Studies of Artemisinin Derivatives for Antimalarial Activity Targeting Plasmepsin II, a Hemoglobin-Degrading Enzyme from P. falciparum

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|37|6133-6154

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.37, 2012-12, pp. : 6133-6154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR and Docking Based Semi-Synthesis and In Vivo Evaluation of Artemisinin Derivatives for Antimalarial Activity

By  

Current Drug Targets, Vol. 15, Iss. 8, 2014-07 ,pp. : 753-761

Bentham Science Publishers

Access to resources Recommend Favorite

Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets

By  

Current Drug Targets, Vol. 16, Iss. 10, 2015-09 ,pp. : 1133-1141

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents

By  

Current Medicinal Chemistry, Vol. 10, Iss. 11, 2003-06 ,pp. : 883-907

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Modeling for the Antimalarial Activity of 1,4-Naphthoquinonyl Derivatives as Potential Antimalarial Agents

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 1, 2013-01 ,pp. : 95-107

Bentham Science Publishers

Access to resources Recommend Favorite

The Mode of Action of the Antimalarial Artemisinin and its Derivatives

By Kamchonwongpaisan S.   Meshnick S.R.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 587-592

Elsevier

Access to resources Recommend Favorite